Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
PodcastThe Directors

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

November 07, 2025
Vol.51 No.41
By Jacquelyn Cobb and Paul Goldberg
Site visits are gone, but outlook for new, centralized CCSG review is bright
Podcast

Site visits are gone, but outlook for new, centralized CCSG review is bright

November 05, 2025
Early endpoints are a balance of risk and benefit
Podcast

Early endpoints are a balance of risk and benefit

October 29, 2025
Vol.51 No.39
Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
Podcast

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

October 22, 2025
Vol.51 No.38
Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
Podcast

Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities

October 15, 2025
Vol.51 No.37
The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
PodcastThe Directors

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

October 10, 2025
Vol.51 No.37
By Claire Marie Porter and Paul Goldberg
Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
Podcast

Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR

October 08, 2025
Vol.51 No.36
With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
Podcast

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

October 01, 2025
Vol.51 No.35
Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.
Podcast

Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.

September 24, 2025
Vol.51 No.34
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
Podcast

Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer

September 17, 2025
Vol.51 No.33

Posts navigation

Previous123456…9Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
    PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.”
  • Protecting the cure: Why the future of radiation oncology must be precision-guided
  • Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
    NCI expects record-breaking spending on extramural research
  • Chernobyl: a 35 year follow up on long-term health effects
  • Cancer AI Alliance announces first wave of pilot projects

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account